M. White et al., PHARMACOKINETIC, HEMODYNAMIC, AND METABOLIC EFFECTS OF CYCLOSPORINE SANDIMMUNE VERSUS THE MICROEMULSION NEORAL IN HEART-TRANSPLANT RECIPIENTS, The Journal of heart and lung transplantation, 16(8), 1997, pp. 787-794
Citations number
29
Categorie Soggetti
Cardiac & Cardiovascular System",Transplantation,"Respiratory System
Background: Cyclosporine is a potent immunosuppressive agent that is,
however, associated with systemic hypertension and renal dysfunction.
The purpose of this investigation was to study the pharmacokinetic and
long-term renal and hypertensive effects of Sandimmune (Sandoz) versu
s the new Neoral (Novartis) formulation of cyclosporine in heart trans
plant recipients. Methods: Twenty heart transplant recipients with sta
ble conditions and aged 54 +/- 9 years were studied in an open-labeled
single-arm conversion protocol. Twelve-hour pharmacokinetic studies w
ere performed on Sandimmune and after 4 weeks of treatment with Neoral
at similar dosage. The 24-hour blood pressure monitoring, creatinine
clearance, and complete biochemistry profile were studied simultaneous
ly to the pharmacokinetic studies. Six-month follow-up with serial mea
surements of cyclosporine levels, and biochemistry profile was complet
ed. Results: Conversion to Neoral resulted in a 24% increase in area-u
nder-the-curve in spite of no significant changes in cyclosporine trou
gh levels (165 +/- 48 [Sandimmune] vs 169 +/- 32 nmol/L; p = 0.26). Re
spectively, 16%, 68%, and 16% were poor, average, and good absorbers o
n Sandimmune versus 26% and 74% being average or good absorbers on Neo
ral. Averaged systolic and diastolic blood pressure were not affected
by Neoral, but blood pressure readings increased in 20% of patients pr
eviously known as having hypertension. The 24-hour blood pressure data
yielded no significant changes with Neoral, but the nocturnal drop in
systolic blood pressure was attenuated by Neoral. Twenty-four-hour cr
eatinine clearance was not affected by Neoral, but serum magnesium lev
els decreased significantly at 6 months. Conclusions: Neoral resulted
in 24% increase in cyclosporine exposure without significant changes i
n trough levels, and improved absorption status. This greater drug exp
osure is well tolerated and resulted in a slight increase in blood pre
ssure in a subset of patients and some decrease in magnesium levels, b
ut it had no effect on renal function.